IP Library Granted Patent US 8,883,988
Granted Patent B2
US 8,883,988 · App. 13/536,909 · Granted Nov 11, 2014

Compositions for use in recombinational cloning of nucleic acids

Inventors: James Hartley (Frederick, MD); Michael Brasch (Gaithersburg, MD); Gary Temple (Washington Grove, MD); David Cheo (Kensington, MD)
Assignee: Life Technologies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,988
App. No.
13/536,909
Granted
Nov 11, 2014
Kind
B2
Abstract

The present invention relates to compositions and methods for use in recombinational cloning of nucleic acid molecules. In particular, the invention relates to nucleic acid molecules encoding one or more recombination sites or portions thereof, to nucleic acid molecules comprising one or more of these recombination site nucleotide sequences and optionally comprising one or more additional physical or functional nucleotide sequences. The invention also relates to vectors comprising nucleic acid molecules of the invention, to host cells comprising vectors or nucleic acid molecules of the invention, to methods of producing polypeptides using nucleic acid molecules of the invention, and to polypeptides encoded by these nucleic acid molecules or produced by methods of the invention. The invention also relates to the use of these compositions in methods for recombinational cloning of nucleic acids, in vitro and in vivo, to provide chimeric DNA molecules that have particular characteristics and/or DNA segments.

Claims (2)

1. An isolated nucleic acid molecule comprising a mutated att recombination site including a core region having a nucleotide sequence selected from agcctgctttattatactaagttggcatta (attL5; SEQ ID NO:87) and agcctgcttttttatattaagttggcatta (attL6; SEQ ID NO:88).

2. An isolated nucleic acid molecule comprising a mutated att recombination site including a core region having a nucleotide sequence selected from the group consisting of ggggacaactttgtacaaaaaagttggct (attB1.6; SEQ ID NO: 105), ggggacaactttgtacaagaaagctgggt (attB2.2; SEQ ID NO:97), and ggggacaactttgtacaagaaagttgggt (attB2.10; SEQ ID NO: 107).

Assignments (3)
MERGER Recorded Oct 3, 2012
From: LIFE TECHNOLOGIES INC.
To: INVITROGEN CORPORATION
Reel/Frame 029072/0370 →
MERGER Recorded Oct 3, 2012
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 029072/0407 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2012
From: HARTLEY, JAMES L.; BRASCH, MICHAEL A.; TEMPLE, GARY F.; CHEO, DAVID
To: LIFE TECHNOLOGIES INC.
Reel/Frame 029024/0404 →
Continuity (6)
Continuation 12649129 · Dec 29, 2009
Continuation 09517466 · Mar 2, 2000
Provisional Application 60136744 · May 28, 1999
Provisional Application 60126049 · Mar 23, 1999
Provisional Application 60122389 · Mar 2, 1999
Related Publication 20130059342A1 · Mar 7, 2013